Additionally, Estradiol valerate was also identified as a potential lifespan-extending drug for both MDD with and without anxiety disorder, by targeting the G protein-coupled estrogen receptor 1 (GPER1) gene. The gene discussed is GPER1; the disease is major depressive disorder.